Assesing the Safety of Antihypertensive medication in Pregnancy (ASAP)

Study summary

No information provided.

Study identification

• EU PAS number:
  EUPAS104849
• Study ID:
  104955
• Official title and acronym:
  Assesing the Safety of Antihypertensive medication in Pregnancy (ASAP)
• DARWIN EU® study:
  No
• Study countries:
  Spain
• Study description:
  No information provided.
• Study status:
  Ongoing

Research institutions and networks

Institutions

The Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO)

Spain

HSRP Unit

Study timelines

Date when funding contract was signed

Planned:01/09/2022

Actual:01/09/2022

Study start date

Planned:01/03/2023

Actual:02/05/2023

Date of final study report

Planned:30/12/2025

Sources of funding

Other

More details on funding

Agencia Estatal de investigación (National Research Agency)

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable